Stockreport

Quanterix’ Simoa Technology Powers Largest and Most Diverse Global Investigation of Plasma Neurofilament Light’s Role in Dementia Diagnosis

Quanterix Corporation  (QTRX) 
US:NASDAQ Investor Relations: ir.quanterix.com/investor-relations
PDF Ultra-sensitive biomarker platform delivers comprehensive evaluation of plasma NfL’s utility across 13 neurodegenerative disorders, Down syndrome and depression BILLE [Read more]